Albayram, Onder http://orcid.org/0000-0002-2028-1458
Kondo, Asami
Mannix, Rebekah
Smith, Colin
Tsai, Cheng-Yu
Li, Chenyu
Herbert, Megan K. http://orcid.org/0000-0003-1599-4362
Qiu, Jianhua
Monuteaux, Michael
Driver, Jane
Yan, Sandra
Gormley, William
Puccio, Ava M.
Okonkwo, David O.
Lucke-Wold, Brandon
Bailes, Julian
Meehan, William
Zeidel, Mark
Lu, Kun Ping
Zhou, Xiao Zhen
Article History
Received: 27 December 2016
Accepted: 16 August 2017
First Online: 17 October 2017
Competing interests
: Dr Lu and Dr Zhou are inventors of Pin1 technology including patents and patent application on tau antibodies, which was licensed by BIDMC to Pinteon Therapeutics. Both Dr Lu and Dr Zhou own equity in, and consult for, Pinteon. Their interests were reviewed and are managed by BIDMC in accordance with its conflict of interest policy. The remaining authors declare no competing financial interests.